189 related articles for article (PubMed ID: 15938647)
1. Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
Mantena SK; Roy AM; Katiyar SK
Photochem Photobiol; 2005; 81(5):1174-9. PubMed ID: 15938647
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair.
Meeran SM; Mantena SK; Elmets CA; Katiyar SK
Cancer Res; 2006 May; 66(10):5512-20. PubMed ID: 16707481
[TBL] [Abstract][Full Text] [Related]
3. Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation.
Mittal A; Piyathilake C; Hara Y; Katiyar SK
Neoplasia; 2003; 5(6):555-65. PubMed ID: 14965448
[TBL] [Abstract][Full Text] [Related]
4. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin.
Vayalil PK; Elmets CA; Katiyar SK
Carcinogenesis; 2003 May; 24(5):927-36. PubMed ID: 12771038
[TBL] [Abstract][Full Text] [Related]
5. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea.
Gensler HL; Timmermann BN; Valcic S; Wächter GA; Dorr R; Dvorakova K; Alberts DS
Nutr Cancer; 1996; 26(3):325-35. PubMed ID: 8910914
[TBL] [Abstract][Full Text] [Related]
6. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors.
Mantena SK; Meeran SM; Elmets CA; Katiyar SK
J Nutr; 2005 Dec; 135(12):2871-7. PubMed ID: 16317135
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress.
Katiyar SK; Mukhtar H
J Leukoc Biol; 2001 May; 69(5):719-26. PubMed ID: 11358979
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
9. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production.
Katiyar SK; Challa A; McCormick TS; Cooper KD; Mukhtar H
Carcinogenesis; 1999 Nov; 20(11):2117-24. PubMed ID: 10545414
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.
Afaq F; Adhami VM; Ahmad N; Mukhtar H
Oncogene; 2003 Feb; 22(7):1035-44. PubMed ID: 12592390
[TBL] [Abstract][Full Text] [Related]
11. Prevention of ultraviolet radiation-induced immunosuppression by (-)-epigallocatechin-3-gallate in mice is mediated through interleukin 12-dependent DNA repair.
Meeran SM; Mantena SK; Katiyar SK
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2272-80. PubMed ID: 16609044
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity.
Barthelman M; Bair WB; Stickland KK; Chen W; Timmermann BN; Valcic S; Dong Z; Bowden GT
Carcinogenesis; 1998 Dec; 19(12):2201-4. PubMed ID: 9886579
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
[TBL] [Abstract][Full Text] [Related]
17. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
Garbisa S; Sartor L; Biggin S; Salvato B; Benelli R; Albini A
Cancer; 2001 Feb; 91(4):822-32. PubMed ID: 11241252
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
19. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
Paul B; Hayes CS; Kim A; Athar M; Gilmour SK
Carcinogenesis; 2005 Jan; 26(1):119-24. PubMed ID: 15375010
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
